MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis

Y. Fan; Alexander Edward Drilon; Chao-Hua Chiu; D.W. Bowles; H.H.F. Loong; Salvatore Siena; K. Goto; M. Krzakowski; M.-J Ahn; H. Murakami; Rafal Dziadziuszko; H. Zeuner; B. Pitcher; D. Cheick; Matthew Krebs

doi:10.1016/j.jtho.2022.07.150

MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis

Y. Fan
, Alexander Edward Drilon
, Chao-Hua Chiu
, D.W. Bowles
, H.H.F. Loong
, Salvatore Siena
, K. Goto
, M. Krzakowski
, M.-J Ahn
, H. Murakami
, Rafal Dziadziuszko
, H. Zeuner
, B. Pitcher
, D. Cheick
, Matthew Krebs

National Cancer Center East Hospital

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S89-S90
Journal	Journal of Thoracic Oncology
Volume	17
DOIs	https://doi.org/10.1016/j.jtho.2022.07.150
Publication status	Published - 1 Sept 2022

Access to Document

10.1016/j.jtho.2022.07.150

Cite this

Fan, Y., Drilon, A. E., Chiu, C.-H., Bowles, D. W., Loong, H. H. F., Siena, S., Goto, K., Krzakowski, M., Ahn, M. .-J., Murakami, H., Dziadziuszko, R., Zeuner, H., Pitcher, B., Cheick, D., & Krebs, M. (2022). MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis. Journal of Thoracic Oncology, 17, S89-S90. https://doi.org/10.1016/j.jtho.2022.07.150

@article{0fab57b15af24125ae008a1fefd7ec8f,

title = "MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis",

author = "Y. Fan and Drilon, \{Alexander Edward\} and Chao-Hua Chiu and D.W. Bowles and H.H.F. Loong and Salvatore Siena and K. Goto and M. Krzakowski and M.-J Ahn and H. Murakami and Rafal Dziadziuszko and H. Zeuner and B. Pitcher and D. Cheick and Matthew Krebs",

year = "2022",

month = sep,

day = "1",

doi = "10.1016/j.jtho.2022.07.150",

language = "English",

volume = "17",

pages = "S89--S90",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier BV",

}

Fan, Y, Drilon, AE, Chiu, C-H, Bowles, DW, Loong, HHF, Siena, S, Goto, K, Krzakowski, M, Ahn, M-J, Murakami, H, Dziadziuszko, R, Zeuner, H, Pitcher, B, Cheick, D & Krebs, M 2022, 'MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis', Journal of Thoracic Oncology, vol. 17, pp. S89-S90. https://doi.org/10.1016/j.jtho.2022.07.150

TY - JOUR

T1 - MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis

AU - Fan, Y.

AU - Drilon, Alexander Edward

AU - Chiu, Chao-Hua

AU - Bowles, D.W.

AU - Loong, H.H.F.

AU - Siena, Salvatore

AU - Goto, K.

AU - Krzakowski, M.

AU - Ahn, M.-J

AU - Murakami, H.

AU - Dziadziuszko, Rafal

AU - Zeuner, H.

AU - Pitcher, B.

AU - Cheick, D.

AU - Krebs, Matthew

PY - 2022/9/1

Y1 - 2022/9/1

U2 - 10.1016/j.jtho.2022.07.150

DO - 10.1016/j.jtho.2022.07.150

M3 - Meeting Abstract

SN - 1556-0864

VL - 17

SP - S89-S90

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

ER -